Epidemiology of hepatocellular carcinoma in Finistère. Prospective study from June 2002 to May 2003;Épidémiologie du carcinome hépatocellulaire dans le département du Finistère. Étude prospective de Juin 2002 à Mai 2003

Gastroenterologie Clinique et Biologique

Volumn 31, Issue 3, 2007, Pages 259-264

  Caumes, Jean Luc ^a,c   Nousbaum, Jean Baptiste ^b   Bessaguet, Christophe ^b   Fayçal, Joseph ^b   Robaszkiewicz, Michel ^b   Gouérou, Hervé ^b  

^a Hop Instruction des Armees Legouest   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

^c Service des Maladies Digestives   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; DISEASE ASSOCIATION; FEMALE; FRANCE; HUMAN; INCIDENTAL FINDING; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PROSPECTIVE STUDY; SEX RATIO;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; FRANCE; HEPATECTOMY; HUMANS; INCIDENCE; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 34147135544     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(07)89370-5     Document Type: Article

References (27)

1. Okuda K. Hepatocellular carcinoma. J Hepatol 2000;32:225-37.
2. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-30.
3. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003;51:3-30.
4. Trinchet JC, Beaugrand M. Augmentation de l'incidence du carcinome hépatocellulaire dans les pays occidentaux. Quelles raisons et quelles conséquences? Gastroenterol Clin Biol 1999;23:1286-8.
5. Benhamiche AM, Faivre C, Minello A, Clinard F, Mitry E, Hillon P, et al. Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995. J Hepatol 1998;29:802-6.
6. Even C, Launoy G, Collet T, Duval O, Piquet MA, Rougereau A, et al. Epidémiologie du carcinome hépatocellulaire dans le département du Calvados. Gastroenterol Clin Biol 1997;21:450-8.
7. Bideau K, Nousbaum JB, Cholet F, Lenormand F, Oger E, Le Berre M, et al. Survie à 5 ans des malades atteints de cirrhose alcoolique après une première hospitalisation (résumé). Gastroenterol Clin Biol 2002;26(Hors Série I):A94.
8. Garcia-Torres ML, Zaragoza A, Giner R, Primo J, del Olmo JA. Incidence and epidemiological factors of hepatocellular carcinoma in Valencia during the year 2000. Rev Esp Enferm Dig 2003;95:385-8.
9. Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxi A, Chiaramonte M, et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998;29:944-52.
10. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
11. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 2003;139:817-23.
12. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997;350:1142-3.
13. De Vos Irvine H, Goldberg D, Hole DJ, McMenamin J. Trends in primary liver cancer. Lancet 1998;351:215-6.
14. Henrion J, Libon E, De Maeght S, Deltenre P, Schapira M, Ghilain JM, et al. Dépistage du carcinome hépatocellulaire dans une cohorte de malades porteurs d'une cirrhose principalement alcoolique. Gastroenterol Clin Biol 2003;27:534-9.
15. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001;48:251-9.
16. Ganne-Carrie N, Chastang C, Chapel F, Munz C, Pateron D, Sibony M, et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 1996;23:1112-8.
17. Trétarre B, Borie F, Bouvier AM, Faivre J, Launoy G, Delafosse P, et al. La prise en charge des cancers primitifs du foie en France. Bull Epidemiol Hebd 2004;43:207-8.
18. Poynard T, Aubert A, Lazizi Y, Bedossa P, Hamelin B, Terris B, et al. Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology 1991;13:896-901.
19. Velazquez RF, Rodriguez M, Navascues CA, Linares A, Perez R, Sotorrios NG, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 2003;37:520-7.
20. Mori M, Hara M, Wada I, Hara T, Yamamoto K, Honda M, et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000;151:131-9.
21. Colombo M, de Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325:675-80.
22. Bralet MP, Regimbeau JM, Pineau P, Dubois S, Loas G, Degos F, et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000;32:200-4.
23. Bernard PH, Blanc JF, Le Bail B, de Ledinghen V, Rullier A, Balabaud C, et al. Carcinome hépatocellulaire sur foie non cirrhotique: un regain d'intérêt. Gastroenterol Clin Biol 1998;22:371-4.
24. Grando-Lemaire V, Guettier C, Chevret S, Beaugrand M, Trinchet JC. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol 1999;31:508-13.
25. Blanc JF, De Ledinghen V, Bernard PH, de Verneuil H, Winnock M, Le Bail B, et al. Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. J Hepatol 2000;32:805-11.
26. Regimbeau JM, Colombat M, Mognol P, Durand F, Abdalla E, Degott C, et al. Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transpl 2004;10:S69-73.
27. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004;126:460-8.